Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Gel Documentation Systems Market Size

ID: MRFR//5443-HCR | 90 Pages | Author: Kinjoll Dey| May 2024

The Gel Documentation Systems market is an important part of life sciences and molecular biology research that is affected by various market forces, which jointly define its future. An important factor is the increased demand for advanced research tools in genomics and proteomics. As scientists move towards a better understanding of genetic materials and proteins, there is need for more sophisticated gel documentation systems to be developed. These systems become crucial in visualizing and analyzing DNA, RNA, as well as proteins separated through electrophoresis because they offer a way out to the researchers who want to find something new.

Additionally, technological advancement plays a critical role in shaping the Gel Documentation Systems market. For example, continuous innovation including introduction of high resolution imaging and automated analysis capabilities means that the market remains dynamic. The need for improved sensitivity and accuracy by researchers and laboratories leads manufacturers into huge investments toward research and development in order to stay ahead among competitors within this competitive landscape. In fact, it can be claimed that further integration of fluorescence or/and chemiluminescence detection into imaging technologies only enhances the attractiveness of this market.

Besides, growing focus on personalized medicine globally and increasing number of studies in cancer biology are also contributing significantly towards growth of Gel Documentation Systems market. Personalized medicine highlights a need for precise and efficient tools for molecular analysis making adoption of gel documentation systems inevitable. Researchers involved in biomarker discovery/validation require these systems so as to develop targeted therapies/diagnostic tools matched with individual patients thereby gaining significance.

Also, biotechnology and pharmaceutical sectors are driving up demand for gel documentation systems. In particular these industries widely apply molecular biology techniques during drug discovery processes right from their inception through production stages. Quality control processes employing gel documentation systems help ascertain that nucleic acids/proteins employed during pharmaceutical applications are uncontaminated thus upholding purity/integrity within such substances. This creates a mutually beneficial relationship between the two industries; one progresses along with another since any developments in one industry directly influence the other.

A further critical factor affecting the Gel Documentation Systems market is global outreach of research and development activities. Collaboration among international research organizations, academic institutions, and biotechnology firms has created a diverse user base with different needs. Consequently, manufacturers have to tailor their products to address specific needs of researchers from all over the world including compatibility with various types of gel as well as simplicity for users and compliance with worldwide standards.

Again, economic factors and budgetary constraints affect purchasing decisions made by laboratories or research facilities. The cost effectiveness of gel documentation systems comprising initial investment, consumables and maintenance influences the outcome of choices. Manufacturers offering competitive prices as well as cost effective solutions will realize a big portion of market share especially in areas where there are restrictions on budgets while procuring goods.”

Gel Documentation Systems Market Overview


The market held a market value of USD 275 Million in 2030 and is projected to grow at a CAGR of 3.6% over the forecast period. For the imaging and recording of nucleic acid and protein suspended inside polyacrylamide or agarose gels, hospitals, diagnostic laboratories, research institutes, pharmaceutical, and biotechnology corporations use gel documentation systems. Ethidium bromide or other fluorophores like SYBR Green are commonly used to stain these gels. These systems have various applications including protein quantification, monoclonal and polyclonal antibody binding affinities, gel and blot imaging, immunoassay, 2D electrophoresis, and nucleic acid quantification.


The global gel documentation system market is expected to expand in the next few years owing to several factors including the rising frequency of infectious diseases and genetic disorders, rising government funding for genomic and proteomic research, and ongoing technological improvements. Due to large clinical R&D spending by both government and commercial pharmaceutical and biotechnological businesses, and increased adoption of new technologies, the Americas are expected to lead the Gel Documentation Systems market.


Gel Documentation Systems Market Segmentation:


The Market has been segmented into Product, Detection techniques, Application and End user.


By product, the market has been segmented into instruments, accessories, and software. The instrument segment has been further segmented into digital gel documentation instruments and film gel documentation instruments. The instruments segment is estimated to hold major market share in the global gel documentation systems market due to the rising R&D activities in the biotechnology and pharmaceutical industries.On the basis of detection technique, the market has been segmented into ultraviolet, chemiluminescence, and fluorescence.On the basis of application, the market has been segmented into protein quantification, nucleic acid quantification, and others.


The market, by end user, has been segmented into pharmaceutical & biotechnology companies, academic institutes & research centers, diagnostic laboratories, and others.The Global Market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The gel documentation systems market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European Gel Documentation Systems Market has been segmented into Western Europe and Eastern Europe. The Western Europe Market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Gel Documentation Systems Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players:


Bio-Rad Laboratories, Inc., Bio-Techne, Endress + Hauser Management AG, GE Healthcare, Thermo Fisher Scientific, LI-COR Biosciences, Vilber Lourmat, Scientific Digital Imaging Plc., Cleaver Scientific, and Azure Biosystems are some of the prominent players in the global gel documentation systems market.


Regional Market Summary


Global Gel Documentation Systems Share (%), by Region, 2017


Source: White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the Gel Documentation Systems industry owing to the high clinical R&D budgets by both government as well as commercial pharmaceutical and biotechnological companies, and rising adoption of advanced technologies. According to the US Investments in Medical and Health Research and Development 2013-2015, a report by Research America, in 2015, total US medical and health R&D in the US was USD 158.7 billion. Moreover, the increasing prevalence of genetic disorders in the region contributes to the market growth.


Europe is expected to hold the second largest position in the Gel Documentation Systems Market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).


The Gel Documentation Systems Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of proteomic and genomic studies in the region.


The Middle East & Africa has the lowest share of the  Gel Documentation Systems Market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.


Global Market, by Product:



  • Instruments

    • Digital Gel Documentation Instruments

    • Film Gel Documentation Instruments



  • Software

  • Accessories


Market for Gel Documentation Systems , by Detection Technique:



Market for Gel Documentation Systems, by Application:



  •       Protein Quantification

  •       Nucleic Acid Quantification

  •       Others


Market for Gel Documentation Systems, by End User:



  •      Pharmaceutical & Biotechnology Companies

  •      Academic Institutes & Research Centers

  •      Diagnostic Laboratories

  •      Others


Market for Gel Documentation Systems, by Region:



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Market for Gel Documentation Systems, by Key Players:



  •      Bio-Rad Laboratories, Inc.

  •      Bio-Techne

  •      Endress + Hauser Management AG

  •      GE Healthcare

  •      Thermo Fisher Scientific

  •       LI-COR Biosciences

  •       Vilber Lourmat

  •       Scientific Digital Imaging Plc.

  •       Cleaver Scientific

  •       Azure Biosystems

  •       Others


Recent Development


A definitive business combination agreement has been reached between Gelesis, Inc., a biotherapeutics company developing biomimetic superabsorbent hydrogels to treat excess weight and metabolic disorders, and Capstar Special Purpose Acquisition Corp., a special purpose acquisition company sponsored by Capstar Partners, LLC affiliates and certain private funds managed by PIMCO. Gelesis hopes to revolutionize weight management with the successful beta launch of its first product, Plenity, which is developed using a unique biomimetic medicinal platform.


Researchers at the Universidad Carlos III de Madrid (UC3M) have created a system that uses computer vision techniques to analyze biomedical movies acquired by microscopy in order to characterize and describe the behavior of the cells shown in the images. These novel methods have been applied to measuring live tissues. As a result, the researchers observed that neutrophils immune cells exhibit several behaviors in the blood during inflammatory processes, one of which is linked to the development of cardiovascular disease and is induced by the Fgr protein.Intended Audience:



  • Gel Documentation System Manufacturers and Distributors

  • Pharmaceutical and Biotechnological Companies

  • Contract Research Organizations

  • Academic and Research Institutes

  • Government Associations

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.